Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
HTRA2 Gene PARK13 Parkinson NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
ATXN8OS Gene Spinocerebellar ataxia type 8, autosomal dominant NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
Spinocerebellar Ataxia 8 CTA/CTG repeat test Neurogenetics Cyprus Institute of Neurology and Genetics Cyprus | 1 | 1 |
|
ATXN8OS - Repeat expansion analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Ataxia / Spastic Paraplegia Comprehensive Panel Centogene AG - the Rare Disease Company Germany | 451 | 452 |
|
Centogene AG - the Rare Disease Company Germany | 13 | 13 |
|
Genomic UnityⓇ Ataxia Repeat Expansion Analysis (STR analysis of 16 loci) Variantyx, Inc. United States | 15 | 13 |
|
Genomic UnityⓇ Comprehensive Ataxia Analysis (includes STR analysis of 16 loci) Variantyx, Inc. United States | 52 | 53 |
|
Genetic Services Laboratory University of Chicago United States | 14 | 14 |
|
SCA8 (ATXN8OS) Repeat Expansion Test Athena Diagnostics United States | 1 | 1 |
|
Molecular Diagnostic Laboratory Diagnostic Services, Shared Health Manitoba Canada | 1 | 1 |
|
Laboratorio de Genetica Clinica SL Spain | 1 | 3 |
|
Genomic Unity® Custom Analysis Variantyx, Inc. United States | 1 | 4054 |
|
Spinocerebellar ataxia: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 38 | 37 |
|
ATXN8OS (Spinocerebellar Ataxia 8) Repeat Expansion Fulgent Genetics United States | 1 | 1 |
|
Ataxia Repeat Expansion Analysis Fulgent Genetics United States | 19 | 15 |
|
Parkinson Disease: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 20 | 24 |
|
Molecular Genetics Laboratory North York General Hospital Canada | 1 | 1 |
|
SPINOCEREBELLAR ATAXIA (AUTOSOMAL DOMINANT) (SCAs) Laboratorio de Genetica Clinica SL Spain | 18 | 19 |
|
Ataxia, Complete Dominant Evaluation Athena Diagnostics United States | 31 | 25 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.